D.W.W. Newling

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)

L. Denis, Jandeilson L. Moura, Aldo Bono et al. · Urology · 1993 · 259 citations

Medicine, Goserelin Acetate, Surgery +1

Maximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853

L. Denis, F. Keuppens, P. H. SMITH et al. · European Urology · 1998 · 168 citations

Endocrine Oncology, Maximal Androgen Blockade, Oncology +11

The Final Analysis of the EORTCGenito-Urinary T ract CancerCo-Operative Group Phase IIIClinical Trial (Protocol 30805)Comparing Orchidectomy,Orchidectomy plus CyproteroneAcetate and Low Dose Stilboestrolin the Management of MetastaticCarcinoma of the Prostate

M. R. G. Robinson, P. H. SMITH, B. Richards et al. · European Urology · 1995 · 103 citations

Prostatic Specific Antigen and the Prediction of Prognosis in Metastatic Prostatic Cancer

E.H. Cooper, T G Armitage, M. R. G. Robinson et al. · Cancer · 1990 · 86 citations

Urology, Oncology, Surgical Oncology +11

Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the european organization for research and treatment of cancer–-genitourinary group study 30853

D.W.W. Newling, L. Denis, K. Vermeylen · Cancer · 1993 · 83 citations

Surgical Oncology, Cancer–-genitourinary Group, Cancer Management +17